[PHARMA] YoY Quarter Result on 30-Sep-2019 [#3]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
20-Nov-2019
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2019
Quarter
30-Sep-2019 [#3]
Profit Trend
QoQ- -94.82%
YoY- -96.8%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
Quarter Result
30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 CAGR
Revenue 924,681 2,132,675 624,804 716,849 587,660 574,503 515,215 10.23%
PBT 15,589 98,219 4,093 3,885 17,603 15,271 19,923 -4.00%
Tax -6,212 -47,895 -2,799 -3,509 -2,298 -11,381 -7,275 -2.59%
NP 9,377 50,324 1,294 376 15,305 3,890 12,648 -4.86%
-
NP to SH 8,617 49,835 1,442 481 15,051 3,580 13,061 -6.69%
-
Tax Rate 39.85% 48.76% 68.39% 90.32% 13.05% 74.53% 36.52% -
Total Cost 915,304 2,082,351 623,510 716,473 572,355 570,613 502,567 10.50%
-
Net Worth 411,327 391,428 345,040 516,387 522,618 531,892 531,250 -4.17%
Dividend
30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 CAGR
Div 7,859 26,182 3,920 - 13,000 12,973 10,365 -4.50%
Div Payout % 91.21% 52.54% 271.91% - 86.38% 362.37% 79.37% -
Equity
30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 CAGR
Net Worth 411,327 391,428 345,040 516,387 522,618 531,892 531,250 -4.17%
NOSH 1,309,126 1,309,126 261,705 261,229 260,505 259,821 259,146 30.97%
Ratio Analysis
30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 CAGR
NP Margin 1.01% 2.36% 0.21% 0.05% 2.60% 0.68% 2.45% -
ROE 2.09% 12.73% 0.42% 0.09% 2.88% 0.67% 2.46% -
Per Share
30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 CAGR
RPS 70.59 162.91 239.03 274.86 226.02 221.42 198.81 -15.84%
EPS 0.66 3.81 0.55 0.18 5.79 1.38 5.04 -28.72%
DPS 0.60 2.00 1.50 0.00 5.00 5.00 4.00 -27.09%
NAPS 0.314 0.299 1.32 1.98 2.01 2.05 2.05 -26.84%
Adjusted Per Share Value based on latest NOSH - 261,229
30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 CAGR
RPS 64.16 147.97 43.35 49.74 40.77 39.86 35.75 10.23%
EPS 0.60 3.46 0.10 0.03 1.04 0.25 0.91 -6.70%
DPS 0.55 1.82 0.27 0.00 0.90 0.90 0.72 -4.38%
NAPS 0.2854 0.2716 0.2394 0.3583 0.3626 0.369 0.3686 -4.17%
Price Multiplier on Financial Quarter End Date
30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 CAGR
Date 30/09/22 30/09/21 30/09/20 30/09/19 28/09/18 29/09/17 30/09/16 -
Price 0.515 0.835 4.32 2.44 2.89 4.14 5.58 -
P/RPS 0.73 0.51 1.81 0.89 1.28 1.87 2.81 -20.11%
P/EPS 78.29 21.93 783.09 1,322.99 49.93 300.05 110.71 -5.60%
EY 1.28 4.56 0.13 0.08 2.00 0.33 0.90 6.04%
DY 1.17 2.40 0.35 0.00 1.73 1.21 0.72 8.42%
P/NAPS 1.64 2.79 3.27 1.23 1.44 2.02 2.72 -8.08%
Price Multiplier on Announcement Date
30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 CAGR
Date 24/11/22 19/11/21 19/11/20 20/11/19 19/11/18 15/11/17 21/11/16 -
Price 0.55 0.845 5.72 2.21 3.09 3.82 5.70 -
P/RPS 0.78 0.52 2.39 0.80 1.37 1.73 2.87 -19.50%
P/EPS 83.61 22.20 1,036.87 1,198.28 53.38 276.85 113.10 -4.90%
EY 1.20 4.51 0.10 0.08 1.87 0.36 0.88 5.30%
DY 1.09 2.37 0.26 0.00 1.62 1.31 0.70 7.65%
P/NAPS 1.75 2.83 4.33 1.12 1.54 1.86 2.78 -7.42%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment